Evidence map›Paper›PMID 40376365›Full record

ArticleCureus2025

A Diagnostic Uncertainty in an Immunocompromised Patient: Rapidly Progressive Interstitial Lung Disease vs. Pneumocystis Pneumonia.

Ibrahim Shamasneh, Neaam Al-Bahadili, Faustina Amable, Mohamad Rezek, Andrew McKown

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ibrahim ShamasnehInternal Medicine, Piedmont Athens Regional Medical Center, AU/UGA Medical Partnership, Athens, USA.
Neaam Al-BahadiliInternal Medicine, Piedmont Athens Regional Medical Center, AU/UGA Medical Partnership, Athens, USA.
Faustina AmableInternal Medicine, Piedmont Athens Regional Medical Center, AU/UGA Medical Partnership, Athens, USA.
Mohamad RezekInternal Medicine, Piedmont Athens Regional Medical Center, AU/UGA Medical Partnership, Athens, USA.
Andrew McKownPulmonary and Critical Care Medicine, Piedmont Athens Regional Medical Center, AU/UGA Medical Partnership, Athens, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic inflammatory myopathies (IIM) are a diverse group of autoimmune disorders characterized by muscle weakness and involvement of extra-muscular organs, including the skin and lungs. The occurrence of interstitial lung disease (ILD) is considered a poor prognostic factor. While antibodies such as anti-Jo-1 and anti-MDA5 are associated with an increased risk of developing ILD, the presence of anti-Mi2 antibodies typically confers a favorable prognosis, with rare lung involvement. This case report presents a diagnostically challenging instance of a patient with positive anti-Mi2 antibodies who developed rapidly progressive ILD (RP-ILD) versus possible Pneumocystis jiroveci pneumonia (PJP).​ We present a 74-year-old Caucasian woman with a history of Stage IV adenocarcinoma with brain metastasis, complicated by vasogenic edema, treated with 12 mg of dexamethasone daily. Two weeks later, she developed proximal muscle weakness and was diagnosed with steroid-induced myopathy. Four weeks afterward, she presented with progressive shortness of breath and hypoxia, requiring high-flow nasal cannula and ICU admission. CT imaging revealed new multifocal opacities with perihilar ground-glass opacities. Review of previous investigations showed linear ground-glass opacities in the left lung and a positive anti-Mi2 autoantibody. The patient was started on intravenous steroids and intravenous immunoglobulin (IVIG) with subsequent improvement. On day five of hospitalization, serum beta-D-glucan returned elevated. Due to overlapping features with PJP, trimethoprim/sulfamethoxazole was initiated. The patient improved significantly and was later discharged on room air. Follow-up imaging six months later showed near-complete resolution. This case highlights the diagnostic complexity in critically ill, immunosuppressed patients with acute respiratory failure, where both autoimmune and infectious etiologies, such as PJP, should be considered.

Indexed as

anti-mi2 antibodiesidiopathic inflammatory myopathiesinterstitial lung diseaseparaneoplastic myositispjp pneumonia

Identifiers

PMID40376365
PMCPMC12080450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.